COMMUNIQUÉS West-GlobeNewswire

-
Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies
04/09/2025 -
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)
04/09/2025 -
Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence
04/09/2025 -
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
04/09/2025 -
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base
04/09/2025 -
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver
04/09/2025 -
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
04/09/2025 -
Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside
04/09/2025 -
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination
04/09/2025 -
Dyadic to Present at Investor Conferences and BPI East
04/09/2025 -
LogicMark Becomes First to Integrate Medication Reminders into Medical Alert Technology
04/09/2025 -
“He’s No Prince” PSA Shatters Fairy Tale Illusions to Expose Emotional Abuse
04/09/2025 -
VIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome (ICOMES)
04/09/2025 -
Raleigh Orthopaedic Implements Full Athelas Product Suite to Enhance Workflow Efficiency and Patient Care
04/09/2025 -
Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Named Pharmacist of the Year by the Florida Society of Health-System Pharmacists
04/09/2025 -
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment
04/09/2025 -
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
04/09/2025 -
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
04/09/2025 -
Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
04/09/2025
Pages